Method for enriching low-abundance protein in serum
A low-abundance protein and serum technology, applied in peptide preparation methods, chemical instruments and methods, animal/human peptides, etc., can solve the problems of low applicability, high cost of use, and high protein loss, and achieve low prices , the effect is good, and the effect of reducing the purification cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Embodiment 1 Heparin affinity chromatography
[0022] In this example, heparin agarose is used as the filler of the purification column, and the sample is subjected to heparin affinity chromatography, and the specific steps are as follows:
[0023] 1. Sample pretreatment
[0024] Collect 10mL of normal human blood into a non-anticoagulant test tube, let it stand at room temperature for 30min, then centrifuge at 1500g for 30min, take the supernatant again at 5000g, centrifuge at 4°C for 20min, remove the precipitate and collect the supernatant, take 100μL of the supernatant, and use 60μL Dilute with purified water and 40 μL of acetonitrile, incubate at 40°C for 15 minutes, centrifuge at 14,000 g for 10 minutes to remove the precipitate, and collect the supernatant as the serum sample in this example.
[0025] 2. Affinity chromatography
[0026] The affinity chromatography in this example adopts the routine operations of those skilled in the art, and the instruments and...
Embodiment 2
[0044] Example 2 Optimization of Heparin Affinity Elution Conditions
[0045] In this example, the elution conditions of the samples of the present invention are optimized, and a series of different formulations are performed on the eluent in Example 1, and the elution effects are compared, so as to select the optimal elution conditions.
[0046] Eluent formulation:
[0047] (1) 10mmol / L Tris-HCl and 0.5mol / L NaCl, pH 7.0;
[0048] (2) 10mmol / L Tris-HCl and 1.0mol / L NaCl, pH 7.0;
[0049] (3) 10mmol / L Tris-HCl and 1.5mol / L NaCl, pH 7.0;
[0050] (4) 10mmol / L Tris-HCl and 2.0mol / L NaCl, pH 7.0.
[0051] At the same time, this embodiment also sets up a comparison group: untreated serum, heparin does not bind to components, and the eluent formula is only 1.5 mol / L NaCl.
[0052] Perform SDS-PAGE electrophoresis on the results after the above different treatments, such as Figure 4 as shown,
[0053] 1 is Marker, 2 is untreated serum, 3 is heparin non-binding fraction, 4-7 a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com